The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2015.
Shares held by Leonard Family Trust, dated August 28, 1996, Keith Richard Leonard, Jr. and Nanette LaRosa Leonard, Trustees.
Shares held by Keith Richard Leonard, Jr., Retained Annuity Trust, Dated 12 April, 2010, Keith Richard Leonard, Jr., Trustee.
Shares held by Nanette LaRosa Leonard, Retained Annuity Tr
ust, Dated 12 April, 2010, Keith Richard Leonard, Jr., Trustee.
Shares held by Keith R. Leonard III. Keith R. Leonard III is the son of the Reporting Person.
Shares held by Nina R. Leonard. Nina R. Leonard is the daughter of the Reporting Person.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.23, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. KYTHERA Biopharmaceuticals next reports earnings on August 07, 2014.
To receive a free e-mail notification whenever KYTHERA Biopharmaceuticals makes a similar move, sign up!
Other recent filings from the company include the following:
KYTHERA Biopharmaceuticals's Chief Financial Officer just cashed-in 375 options - Nov. 20, 2014
Kythera Biopharmaceuticals Releases Third Quarter 2014 Operating Results - Nov. 10, 2014
KYTHERA Biopharmaceuticals Just Filed Its Quarterly Report: 9. Basic and Dilu... - Nov. 10, 2014
KYTHERA Biopharmaceuticals Just Received a Notice of Effectiveness - Nov. 6, 2014
Registration statement under Securities Act of 1933 - Nov. 6, 2014